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The human Ia antigens are encoded within the HLA complex on chromosome 
six  and  are  borne  on  molecules  composed  of two  noncovalently associated 
glycoproteins of-34,000 daltons (a chains) and ~28,000 daltons (/3 chains). Ia 
antigens are important in the effective collaboration between immunocompetent 
cells in the generation of immune responses; they have also been associated with 
putative immune response genes and the predisposition to the development of 
certain diseases.  Three types of human Ia molecules have been identified and 
biochemically characterized: DR, DS (or DC), and SB. DR molecules are defined 
by their N-terminal amino acid sequence homology to murine I-E molecules (1- 
3).  HLA-DR  homozygous cells  appear  to  express  a  single  DR  a  chain  that 
associates with either of two distinct DR/3 chains to form two heterodimeric DR 
molecules  (2,  3).  SB  molecules appear  to  be  structurally different from  the 
corresponding  DR  molecules,  although  SB  a  chains,  like  DR  a  chains,  are 
homologous to murine I-E  0~ chains (4).  DS  (or DC) molecules are defined by 
their N-terminal amino acid sequence homology to murine I-A molecules (1, 5). 
Although previous studies indicated that HLA-DR homozygous cells express a 
single DS molecule, we have recently shown that an HLA-DR5 homozygous cell 
line expresses at least two distinct DS molecules (6). Therefore, existing evidence 
at the protein level indicates that HLA-DR homozygous cell lines express at least 
five Ia molecules: two DR molecules, two DS molecules, and one SB molecule. 
Serologic  testing  with  anti-Ia  allosera  has  identified two  major  groups  of 
serologically defined Ia  alloantigens:  the  HLA-DR antigens  and  the  non-DR 
antigens including the MB (7, 8), MT (9), LB (10),  Te (1 1), DC (12,  13), and BR 
(14-16)  alloantigen systems. The serologically defined non-DR  Ia alloantigen 
systems share  the common feature that each specificity is found in association 
with  two  or  more  HLA-DR  antigens.  The  determination  of the  molecular 
relationships of these serologically defined Ia alloantigens to the biochemically 
defined Ia molecules (DR, DC, SB) has been the focus of considerable interest. 
In general, the biochemically defined DR molecules appear to bear the serolog- 
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ically defined  HLA-DR  allodeterminants.  Several  of the  seroiogically defined 
non-DR  Ia alloantigens  (MB1,  DC1,  MT1,  LB12  [5,  17-19];  MB3  [6,  13,  19, 
20];  and  MT4  [6])  appear  to  reside  primarily  on  DS  molecules.  The  MT2 
determinant appears to reside on both DR and DS molecules from the same cell 
(6). The location of the  MT3  determinant  is variable:  on  DR4  cells,  the  MT3 
determinant resides on DS molecules, while on DR7 cells, the MT3 determinant 
is found on DR molecules (18,  19). 
The  MB1,  MT1,  DC1,  and  LB12  allospecificities are  expressed  in  linkage 
disequilibrium  with  DR1,  DR2, and  DRw6.  It is thought that the MB1,  MT1, 
DC 1, and LB12 specificities are identical (17); therefore, this group of presum- 
ably identical specificities will be referred to as MB 1. Two monoclonal antibodies, 
Genox 3.53  (21) and  BT3.4  (22),  have been described that define specificities 
with the same distribution (DR1, DR2, and DRw6) as the MB1 allodeterminant. 
The determinants defined by these monoclonal antibodies will be referred to as 
MBl-like to denote their possible differences from the MB1 allodeterminant. A 
previous report (17) indicated that both the MB 1 allodeterminant and the MB1- 
like  determinant  defined  by  Genox  3.53  reside  on  the  single  DS  molecule 
identified in those studies. In the present study, the molecular specificities of two 
anti-MBl-like  monoclonal  antibodies  and  two  anti-MB1  allosera  have  been 
examined in  light of the recent evidence that  HLA-DR  homozygous cell lines 
may express at least two DS molecules (6). 
The data  presented here indicate  that  an  HLA-DRw6  homozygous cell line 
expresses at  least  two  distinct  DS  o~ chains  and  two  distinct  DS  /3  chains  that 
associate  to  form at  least  two  heterodimeric  DS  molecules.  In  addition,  these 
studies document for the first time that anti-Ia reagents which are specific for 
the  MB1  or  MBl-like determinants  in  population  studies  do not all  recognize 
the same Ia molecules in immunochemical studies. 
Materials and  Methods 
Cells.  The B lymphoblastoid cell line ELD, HLA-A2, A2; B40, B40; DRw6,  DRw6; 
Dw6, Dw6;  MB1;  MT1, MT2, was obtained from Dr. John Hansen (Fred Hutchinson 
Cancer Research Center, Seattle, Washington) (23). 
Anti-Ia  Reagents.  SG157  is  an  anti-Ia  monoclonal antibody that  is  specific for DR 
molecules; the a and/3 chains of Ia molecules isolated with SG157 have N-terminal amino 
acid sequences that are homologous to the a  and/3 chains, respectively, of murine I-E 
molecules (1). RbO3 is a rabbit antiserum specific for human Ia molecules (DS) that have 
N-terminal amino acid sequence homology to murine I-A molecules (1).  RbO3 isolated 
no DR molecules from multiple cell lines in previous two-dimensional (2-D) 1 gel studies 
(1, 6,  18,  19).  BT3.4 (22) and Genox 3,53 (21) are anti-Ia monoclonal antibodies that 
bind only to DRI-, DR2-, and DRw6-positive cells.  Therefore, BT3.4 and Genox 3.53 
appear to define antigenic determinants similar to the MB1/MT1/LB12/DC1  determi- 
nants  defined by allosera.  BT3.4  was  provided by  Dr.  Giorgio Corte  (Universita  di 
Genova, Genoa, Italy). L243 and L227 are anti-Ia monoclonal antibodies that recognize 
nonpolymorphic determinants on DR molecules (24); they have been shown to isolate Ia 
c~ and/3 chains having N-terminal amino acid sequence homology to the a and/3 chains, 
respectively, ofmurine I-E molecules (2, 3). The L243, L227, and Genox 3.53 hybridomas 
were obtained from the American Type Culture Collection, Rockville, MD. Baron and 
1Abbreviations  used  in  this paper:  2-D, two-dimensional; SaCI, protein  A-bearing Staphylococcus 
aureus,  Cowan I strain;  IEF, isolectric focusing; NP-40, Nonidet  P-40; PBS, phosphate-buffered 
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Dobbe are anti-MB1  allosera from the Blood Center of Southeastern Wisconsin,  Inc. 
Dobbe was serum 119 in the Eighth International Histocompatibility Workshop (25). The 
donor of serum Baron types as HLA-A 1, Aw31; B8, Bw35; DR3, DR4; MB2, MB3; MT2, 
MT3; the immunizer types as HLA-Aw26, Aw30; B7,  Bw51;  DR2,  DR4; MB1,  MB3; 
MT1, MT3. The donor of serum Dobbe types as HLA-A2, A3; Bw51, Bw62; DR4, DR5; 
MB3; MT2, MT3; the immunizing haplotype is HLA-A11; Bw35; DR1; MB1; MT1. 
Preparation of Radiolabeled Antigens.  Cells of the B lymphoblastoid cell line ELD were 
resuspended at 3 x  106/ml  in RPMI  1640  lacking leucine and methionine and supple- 
mented with 10% dialyzed fetal bovine serum. [3H]leucine (130-190 Ci/mM; Amersham 
Corp., Arlington Heights, IL) and [sSS]methionine (>600 Ci/mM; Amersham Corp.) were 
each added to a concentration of 400 #Ci/ml and the cultures were incubated for 8 h at 
37°C in a humidified 7% CO2 atmosphere. The cells were harvested and washed three 
times with Hanks' balanced salt solution before they were solubilized for 30 min at 4°C 
in phosphate-buffered saline (PBS) containing 0.5% of the non-ionic detergent Nonidet 
P-40 (NP-40) (Particle Data, Inc., EImhurst, IL), 200 ~g/ml phenylmethylsulfonyl  fluoride 
(PMSF), 50 #g/ml L-l-tosylamide-2-phenylethyl  chloromethyl ketone (TPCK), and 50/~g/ 
ml N-a-p-tosyl-L-lysine chloromethyl ketone HCI (TLCK) (Sigma Chemical Co., St. Louis, 
MO).  Insoluble material was removed by ultracentrifugation at  100,000 g for 60 min. 
Before immunoprecipitation with the specific anti-Ia reagents, the radiolabeled antigen 
preparations were precleared with normal human serum, rabbit anti-mouse immunogiob- 
ulin,  and  protein  A-bearing  Staphylococcus aureus,  Cowan  I  strain  (SaCI)  (Pansorbin; 
Calbiochem-Behring Corp., San Diego CA) to remove radiolabeled immunoglobulin. 
lmmunoprecipitation.  Aliquots of the antigen preparations were incubated overnight at 
4°C with the various anti-Ia reagents. The monoclonal antibodies BT3.4, Genox 3.53, 
L243, and L227 do not bind to SaCI.  Therefore, in immunoprecipitations with these 
reagents, rabbit anti-mouse immunoglobulin was added to the antigen-antibody mixture 
before the SaCI immunoadsorbent was added. After the immunoprecipitations, the SaCI 
pellets  were  washed  three  times  with  PBS  containing 0.25%  NP-40  before  elution 
according  to  the  method  of O'Farrell  (26).  For  the  sequential  immunoprecipitation 
experiments, an aliquot of antigen preparation was immunoprecipitated three times with 
the preclearing anti-Ia reagent. This precleared aliquot was then divided into two equal 
portions which were immunoprecipitated with the preclearing reagent (negative control) 
and the test reagent, respectively. 
2-D Gel Electrophoresis.  2-D gel electrophoresis was performed according to the method 
of O'Farrell (26) with some modifications. The first dimension separation by isoelectric 
focusing (IEF)  was performed in 5 ×  125-mm cylindrical gels containing a  mixture of 
0.6% (wt/vol, pH 3.5-10), 0.4% (pH 8-9.5), and 1% (pH 5-8) Ampholine (LKB Instru- 
ments, Rockville,  MD). The IEF gels were electrophoresed at 600 V for 16 h and were 
then imbedded in agarose on the top of a slab gel with a 3-cm 4% stacking segment and 
a  13-cm  sodium  dodecyl sulfate-12.5%  polyacrylamide separating  segment prepared 
according to the method of Laemmli (27). The slab gels were fixed in a solution containing 
10%  (vol/vol) glacial  acetic acid and 40%  (vol/vol)  methanol before fluorography was 
performed using EN3HANCE (New England Nuclear, Boston, MA). The dried gels were 
exposed to Kodak X-omat AR5 film at -70°C. 
Results 
A biosynthetically radiolabeled antigen preparation of the DRw6 homozygous 
cell line, ELD, was immunoprecipitated with several anti-Ia reagents; the precip- 
itated material was analyzed by 2-D gels (Fig.  1). The various Ia a  and/3 chains 
identified in these studies are indicated in Fig.  1 and are shown schematically in 
Fig. 7. The t3 chain pattern of Ia molecules isolated by the DR-specific monoclonal 
antibody SG157  consists of four major spots and two less intense spots. The/3 
chain pattern of Ia molecules isolated by the anti-Ia monoclonal antibody L227 
is identical to the acidic portion of the SG157/3 pattern. This is not unexpected FIGURE  1.  Fluorographs of 2-D gels of Ia molecules precipitated from a radiolabeled antigen 
preparation of the DRw6 homozygous cell line, ELD, by the anti-la reagents listed at the left. 
The cr and/3 chain portions of the gels are designated by brackets at the top.  For the SG157 
+  RbO3, RbO3  +  BT3.4,  and RbO3  +  Genox gels, individual precipitates were mixed and 
analyzed together by IEF. In the SG157 +  RbO3 gel, the two vertical arrows mark DR3~,  the 
two  diagonal  arrows  mark  the  coincident  spots  of  DRfl~ and  DS3~,  and  the  two  lower 
arrowheads mark DS32.  In the Genox 3.fi3 gel, the horizontal arrow marks the faint spots of 
DS3t. 
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since SG157  and  L227  have both been shown to isolate DR molecules (1-3). 
However, the  L227  pattern  lacks the two  major  basic  spots  in  the  SG157  3 
pattern.  These data suggest that the SG157  3  pattern may be produced by at 
least two distinct DR 3 chains. Additional studies (discussed below) have shown 
that the SG157/3 pattern is produced by at least two distinct DR 3 chains, which 
will be referred to as DR3x (isolated by L227 and SG157) and DR/32 (isolated by 
SG157 but not L227). The DS/3 chain pattern of RbO3 consists of four major 
spots with isoelectric points similar to the major spots in the SG157/3 pattern. In 
addition,  the  RbO3  pattern  also  includes  two  less  intense  spots.  Based  on 
additional studies discussed below, the RbO3  /3 pattern is produced by at least 
two distinct DS/3 chains, DS/31 and DS/32. 
As expected, the DR and DS c~ chain patterns in the SG157 and RbO3 gels, 
respectively, also differ. Because some of the ~ chain patterns shown in Fig.  1 
are more intense than  the /3 chain patterns,  shorter exposures of the 0~ chain 
portions  of some gels are shown  in  Fig.  4  for clarity. The  SG157  a  pattern 
consists of three closely spaced spots with similar molecular weights; this pattern 
is produced by the single DR a chain (DRa) expressed by this cell line. The L227 
pattern  is  very similar to the SG157  a  pattern.  Based on additional studies 
discussed below, the more complex RbO3 a pattern appears to consist of at least 
two distinct DS a  chains as indicated in Fig.  1  : a lower molecular weight a  chain 
consisting of four spots (DSal) and a  slightly higher molecular weight ~  chain 
also consisting of four spots (DS0~2). 
To more definitively compare the DR and DS Ia molecules, individual SG157 
and RbO3 immunoprecipitates were mixed and analyzed together in the same 
IEF gel. This method eliminates the variables of stretching of the individual IEF 
gels and differences in separation in the second dimension gels. The SG157  + 
RbO3  gel demonstrates that  the spots  of DS/32  isolated  by  RbO3  are clearly 
distinct  from the spots  of DR32  isolated by SG157.  These  DS32 spots  (lower 
arrowheads) are slightly more acidic and are lower in molecular weight than the 
DR32 spots (vertical arrows). By contrast, the two most acidic spots of the RbO3 
/3 pattern appear to co-migrate with the two intense acidic spots in the SG157 
pattern (diagonal arrows). A  SG157  +  BT3.4  mixing gel (data not shown) was 
identical to the SG157 +  RbO3 gel. Because the Ia molecules isolated by SG 157 
and RbO3  have been shown to have distinct N-terminal amino acid sequences 
(1),  these coincident spots presumably represent glycosylated forms of distinct 
proteins that have similar physical characteristics when analyzed by this 2-D gel 
method. The relationship of these coincident spots of Ia molecules isolated by 
SG157,  RbO3,  and BT3.4  has been further investigated and will be discussed 
below. The a  chain pattern in the SG157  +  RbO3  gel demonstrates that DRa 
and the DS a  chains have very similar isoelectric points and molecular weights 
when analyzed by this 2-D gel technique. 
Two anti-MBl-like monoclonal antibodies, BT3.4 and Genox 3.53, were also 
used to isolate Ia molecules from the ELD antigen preparation.  The BT3.4/3 
pattern consists of five major spots that are similar to the RbO3 pattern. However, 
compared with the RbO3 gel, the two most acidic, higher molecular weight spots 
in  the  BT3.4  pattern  are more intense than the basic spots.  This  differential 
intensity of the acidic 3 spots compared with the basic 3 spots suggests that the KARR  ET  AL.  1517 
BT3.4/3 pattern is produced by two distinct/3 chains. The Genox 3.53/3 pattern 
also consists of five major spots and is very similar to the RbO3  and BT3.4  /3 
patterns; however, in contrast to the BT3.4 pattern, the two most acidic, higher 
molecular weight spots in the Genox 3.53 gel are relatively less intense than the 
two major basic spots. These reciprocal quantitative differences in the intensities 
of these two pairs of/3 chain spots in the BT3.4  and Genox 3.53  gels suggest 
that the two most acidic, higher molecular weight spots isolated by BT3.4, Genox 
3.53, and RbO3 belong to one distinct DS/3 chain (DS/3~), while the two major 
basic spots isolated by BT3.4, Genox 3.53, and RbO3 belong to a second distinct 
DS/3 chain  (DS/32). Therefore, as indicated in  Fig.  1,  the BT3.4  /3 pattern is 
formed by DS/31 and DS/3~. The Genox 3.53/3 pattern contains DS/3~ and a lesser 
amount of DS/31 (horizontal arrow). 
To more definitively compare the Ia molecules isolated by RbO3, BT3.4, and 
Genox  3.53,  immunoprecipitates with  RbO3  and BT3.4  were mixed and im- 
munoprecipitates with  RbO3  and  Genox  3.53  were mixed and  the mixtures 
analyzed by 2-D gels. The RbO3 +  BT3.4/3 pattern demonstrates co-migration 
of the major/3 chain spots isolated by RbO3 and BT3.4.  In addition to the five 
major DS/3 chain spots,  two other spots are visible in the RbO3  +  BT3.4  gel 
that  are  only  faintly  visible  in  the  individual  RbO3  and  BT3.4  gels.  This 
presumably results from the additive effect of minor components in both indi- 
vidual precipitates.  The RbO3  +  Genox 3.53  /3 pattern also demonstrates co- 
migration  of the  major  /3  spots  isolated  by  RbO3  and  Genox  3.53  and  is 
qualitatively very similar to the RbO3 +  BT3.4 gel. As with the RbO3 +  BT3.4 
gel, two spots that are only faintly visible in the individual gels are better seen in 
the RbO3 + Genox 3.53 gel. In a BT3.4 + Genox 3.53 mixing experiment (data 
not shown), the DS /3 spots are also coincident. Taken together, these mixing 
experiments document that the DS/3 spots isolated by RbO3, BT3.4, and Genox 
3.53 are coincident and that these reagents isolated Ia molecules containing both 
major DS/3 chains. 
Two anti-MB 1 allosera, Baron and Dobbe, were also used to isolate Ia mole- 
cules from the ELD antigen preparation.  Both  the Baron and Dobbe /3 chain 
patterns contain two intense basic spots and two less intense basic spots. The two 
prominent basic spots in the Baron and Dobbe gels are very similar to the spots 
of D8/32  in the RbO3,  BT3.4,  and Genox 3.53  gels. The Baron and Dobbe a 
chain patterns are identical and correspond to the DSa2 chain. Therefore, two 
anti-MB1  allosera isolated the molecule composed of DSa2:DS3~.  The isolation 
of D8/32  in  the absence of DS/31 provides additional evidence that  the RbO3, 
BT3.4,  and Genox 3.53  /3 patterns are composed of two distinct DS/3 chains. 
These data with Baron and Dobbe also establish that the molecular specificities 
of MB 1 allosera differ from the molecular specificities of two MB l-like monocio- 
nal antibodies. 
To formally demonstrate that the/3 chain isolated by Baron and Dobbe is the 
same as  DS/3~ isolated  by  RbO3,  BT3.4,  and  Genox  3.53,  additional  mixing 
experiments were performed with  another  ELD  antigen  preparation.  The  /3 
chain portions of these gels are shown in Fig. 2. The individual Baron and RbO3 
/3 chain patterns are similar to those in Fig.  1; the Baron/3 pattern consists of 
DS/3~ only, while the RbO3 pattern includes DS31 and DS/3~. The Baron +  RbO3 1518  COMPLEXITY  OF  HLA-DS MOLECULES 
FIGURE 2.  Fluorographs of the B chain portions of 2-D gels of Ia molecules isolated by the 
anti-Ia reagents listed at the left. For the Baron + RbO3 and Baron + SG157 gels, individual 
precipitates were mixed and analyzed together by IEF. 
gel demonstrates that the basic spots in  the Baron pattern co-migrate with  the 
spots of DS/32 isolated by RbO3.  Therefore, Baron and Dobbe clearly isolate Ia 
molecules containing DS/3~. The Baron +  SG157 gel demonstrates that the spots 
of D8/32 isolated by Baron are clearly distinct from the spots of DR/32 isolated by 
SG 157. The relationship between the DR/32 and DS/3e in the Baron +  SG 157 gel 
is identical to the relationship between the same chains in the SG157  +  RbO3 
gel in Fig.  1. 
The/3 pattern in the Genox 3.53 gel in Fig.  1 suggests that the spots of DS/3~ 
are relatively less intense than the spots of D8/32. Additional studies demonstrate KARR  ET  AL.  1519 
FIGURE 3.  Fluorographs  of the ¢~ chain portions of 2-D gels of Ia molecules  precipitated by 
Genox 3.53 and RbO3 from an ELD antigen preparation. The fluorograph of the Genox 
3.53 gel in the second panel was exposed six times longer than the fluorograph in the top 
panel. The arrows in each panel indicate the position of the spots  of DS/3]. 
this point  more  clearly.  The  Genox  3.53  /3 pattern  in  the  top panel  of Fig.  3 
consists primarily of DS/32 and a very faint amount of DS/31 (arrows). The middle 
panel  shows the same 2-D gel,  in  which the  fluorograph  has been exposed six 
times longer than  the fluorograph  in the top panel; the DS/31 spots (arrows) are 
now more easily seen, but they are still  much less intense than  the DS/3~ spots. 
The  RbO3  gel  from  the  same  experiment  is  shown  in  the  bottom  panel  to 
document that  DS/3~ (arrows) is adequately radiolabeled in the antigen prepara- 
tion used in these studies. These data provide additional evidence that DS/3~ and 
DS/32 are distinct/3 chains.  Moreover, the finding that DS/31 may be only faintly 
visible in some Genox 3.53 gels, while DS/32 is always clearly visible, may provide 
an explanation for the previous observation that Genox 3.53 immunoprecipitates 
from another  DRw6 homozygous cell line contained only a  single/3 chain  (28) 
analogous to DS/3z. 
Because the 0¢ chain portions of some of the fluorographs shown in Fig.  1 are 
slightly  overexposed  and  do  not  permit  optimal  examination  of the  o~  chain 
patterns,  additional  exposures of the o~ chain portion of selected gels from Fig. 
1 are shown in Fig. 4. Taken together, these data indicate that the ELD cell line 
expresses at least two distinct DS a  chains.  The ¢~ chain data are also presented 
schematically in Fig. 7. The Dobbe ot chain pattern consists of four spots that are 
arranged  in a  stair-step pattern  of increasing  molecular weights from the most 
basic to the most acidic. This pattern is designated DSot  2 and is also found in the 
Baron gel. There is no evidence of DSal in the Baron or Dobbe gels. The BT3.4 
pattern consists of DSa~ and another lower molecular weight o~ chain referred 
to as DSoq. There is some minor electrophoretic distortion of the ot chains in the 
individual  BT3.4 gel; a better resolved pattern  is shown in the RbO3 +  BT3.4 
gel.  DSa~  consists of four spots that are also arranged  in a  stair-step pattern  of 
increasing molecular weights from the most basic to the most acidic. Each spot 
of DSt~ has a slightly lower molecular weight than the proximate spot of DSot~. 
Although  DSt~  is not isolated alone by any of the DS reagents,  the isolation of 
DSo~2 without DSoq by Baron and Dobbe strongly indicates that DSal is a distinct 
entity. The Genox  3.53  t~ pattern  consists of three spots and is clearly distinct 1520  COMPLEXITY OF  HLA-DS MOLECULES 
FIGURE 4.  Fluorographs  of the a chain portions of 2-D gels of Ia molecules isolated by the 
anti-la reagents listed beside each gel. These are shorter exposures of the same gels shown in 
Fig. 1. 
from the DS 0z patterns in the Dobbe, Baron, BT3.4, and RbO3 gels. The major, 
lower molecular weight spot (horizontal arrow) in the Genox 3.53 o~ pattern co- 
migrates with the more acidic spots of the DSoq pattern in the RbO3 +  Genox 
gel. The Genox 3.53 ~ pattern lacks the more basic spots of DSoq that are seen 
in  the  BT3.4  and  RbO3  gels.  The  two  less  intense,  higher molecular weight 
spots (vertical arrows) in the Genox 3.53 a  pattern are closely related to two of 
the four spots of DSo~2; however, the other spots of DSo~2 are not present in the 
Genox 3.53 gel. Therefore, the three spots in the Genox 3.53 a  pattern may be 
biosynthetic precursors of DS~ and/or DSoL2 or they may represent one or more 
additional distinct DS a chains. The complex RbO3 ~ pattern includes DSal and 
DSol2.  In  addition,  the  RbO3  a  pattern  contains  a  spot  (horizontal  arrow) 
analogous to the  major spot  in  the  Genox a  pattern.  The  RbO3  +  BT3.4 
pattern  clearly demonstrates  the  relationship  between  DSa~ and  DSaz.  The 
RbO3  +  Genox 3.53  a  pattern shows that the a  chain spots isolated by Genox 
3.53  co-migrate with  the  spots  isolated by  RbO3.  The  spot  indicated by the 
horizontal arrow in the RbO3 +  Genox gel corresponds to the major spot in the 
individual Genox  3.53  gel.  Therefore, at  least  two distinct DS  a  chains have 
been isolated from this DRw6 homozygous cell line. 
To further define the DR/3 chains, a sequential immunoprecipitation experi- 
ment was  done;  the  /3  chain portions  of these  2-D  gels are  shown in  Fig.  5. 
Another ELD antigen preparation was precipitated with the DR-specific reagents 
L227 and L243. The L243/3 chain pattern is identical to the pattern of DR/3 
chains isolated by SG157. The L243 a chain pattern (data not shown) is identical KARR  ET  AL.  1521 
FIGURE 5.  Fluorographs  of the 3 chain portions of 2-D gels of la molecules  precipitated by 
the anti-DR reagents, L243 and L227, from an ELD antigen preparation. The first two panels 
show 3 chains of la molecules  isolated by direct precipitation with L243 and L227. The two 
lower panels show a sequential immunoprecipitation experiment in which an aliquot of the 
antigen preparation was first depleted of L227-reactive material and then divided into two 
aliquots before immunoprecipitation with L227 (L227/L227) or L243 (L227/L243), respec- 
tively. 
to the SG157 a  chain  pattern  in  Fig.  1.  As before, the L227/3 pattern  consists 
only of four acidic spots (DR31) that  are also present  in  the SG157  and  L243 
patterns.  An  aliquot of the antigen  preparation  was depleted of L227-reactive 
material  and was then  divided into two aliquots that were immunoprecipitated 
with  L227 and  L243,  respectively.  Immunoprecipitation  of the antigen  prepa- 
ration  with L227 with removal of L227-reactive material  (L227/L227) isolated 
no  Ia  molecules.  This  result  documents  that  all  of the  L227-reactive  material 
had been removed in the initial precipitations. Immunoprecipitation of the L227- 
depleted antigen preparation with L243 (L227/L243) isolated a/3 chain pattern 
that corresponds to the basic portion of the L243 and SG157/3 patterns (DR32). 
These results document that the ELD cell line expresses at least two DR/3 chains, 
designated DRB1 and DR/32. 
The SG157  +  RbO3 gel (Fig.  1) and a SG157 +  BT3.4 gel (data not shown) 
indicate that  the spots of DSfll  isolated by RbO3, BT3.4, and  Genox  3.53 are 
coincident  with  the  spots  of  DR3~  isolated  by  SG157,  L243,  and  L227.  As 
discussed previously, these coincident spots are presumably components of dis- 
tinct  glycoproteins  that  have  the  same  physical  characteristics  in  the  2-D  gel 
system.  To  more  clearly  define  the  relationships  of these  coincident  spots,  a 
sequential  immunoprecipitation  experiment  was  performed  with  SG157  and 
BT3.4; the fl chain  portions of these  2-D gels are shown in Fig 6.  The/3 chain 
patterns in the individual SG157 and BT3.4 gels are the same as in Fig.  1. The 
SG157/3 pattern  includes DR/3~ and  DR32, while the BT3.4 /3 pattern  includes 
DS31  and  D8/32. Immunoprecipitation  of the antigen  preparation  with  SG157 
after removal of SG157-reactive  material  (SG157/SG157)  isolated no  Ia mole- 
cules.  This  result  documents that  all  of the  SG157-reactive  material  has  been 
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FIGURE 6.  Fluorographs of the fl chain portions of 2-D gels of Ia molecules precipitated by 
SG157 and BT3.4 from an ELD antigen preparation. The first two panels show the fl chains 
of la  molecules isolated by  SG157 and  BT3.4.  The four lower panels show sequential 
immunoprecipitation experiments  in  which aliquots of the  antigen  preparation  were  first 
depleted of SG157-reactive material or BT3.4-reactive material and then divided into two 
aliquots before immunoprecipitation with SG 157 (SG  157/SG 157 and BT3.4/SG  157) or BT3.4 
(BT3,4/BT3.4 and SG 157/BT3.4). 
antigen preparation with BT3.4 (SG157/BT3.4) isolated a/3 chain pattern (DSfll 
and DS/32) that is identical to the direct BT3.4 precipitate. Immunoprecipitation 
of the antigen preparation with BT3.4 after removal of BT3.4-reactive material 
(BT3.4/BT3.4)  isolated  no  Ia  molecules.  Immunoprecipitation  of the  BT3.4- 
depleted  antigen  preparation  with  SG157  (BT3.4/SG157)  isolated  a  /3  chain 
pattern (DR/3~ and DR/3~) identical to the direct SG157 precipitate. These results 
document  that  the  coincident  spots  of DR/3~ (isolated  by  SG157,  L227,  and 
L243) and  DSfll  (isolated by BT3.4,  RbO3,  and  Genox 3.53) are  indeed com- 
ponents of distinct Ia/3 chains. 
The relationships of the Ia a  and/3 chains identified in these 2-D gel studies 
are  shown  schematically  in  Fig.  7.  The  single  DR  a  chain  and  the  two  DS 
chains are depicted in panels  a-c.  Panel a  shows the DR~ chain that is isolated 
by SG157,  L227, and L243. The DSal  and DSol  2 chains are shown in b. BT3.4 
and RbO3 isolated DSa~ and DSa~. Panel c shows DSc~, which is isolated without 
other 0l chains by Baron and Dobbe. Panel d  shows the ~  chain pattern isolated 
by  Genox  3.53;  the  three  spots  in  the  Genox  3.53  ~  pattern  may  represent 
additional distinct DS 0t chains or biosynthetic precursors of DS~  or DSa~. The 
relationships of the two DR/3 chains and two DS/3 chains are shown  in e. The KARR  ET  AL.  1523 
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FIGURE 7.  Schematic diagrams of the Ia a and B chains isolated from the ELD cell line. The 
a  chain schematics (a-d) depict the patterns seen in these gels; (a) SG157, L227, and L243; 
(b) BT3.4; (c) Baron and Dobbe; and (d) Genox 3.53. The four B chains are shown in e. DRBI 
is shown as two closed spots and two spots that are half closed and half open to indicate that 
these latter spots of DRB~ co-migrate with the two spots of DSB1. DRB2 is shown as hatched 
spots, DSB~ as open. 
four spots of DR/3a are shown as two closed spots and two spots that are half- 
closed and half-open to indicate that these DR/3] spots co-migrate with the two 
spots of DS/3I. The spots of DR/~ are hatched; those of DS/~ are open. 
Discussion 
These studies were initiated to better define (a) the molecular complexity of 
human DS molecules and (b) the relationship of the DS molecules that bear the 
MB1  allodeterminant and  the  MBl-like determinants defined by monoclonal 
antibodies. The data presented here document for the first time that an HLA- 
DRw6 homozygous cell line expresses at least two distinct DS  a  chains. These 
two DS a chains associate with two DS B chains to form at least two DS molecules. 
In addition, the cell line was shown to express two DR/3 chains and one DR 
chain that combine to form two DR molecules. The MB1 allosera and MBl-like 
monoclonal antibodies used in these studies do not all recognize determinants 
on the same  DS  molecules. Therefore, these data also document for the first 
time that there is heterogeneity of the molecular specificities of anti-Ia reagents 
that define the MB1  and MBl-like antigens in population studies. 
The MB 1 allosera, Baron and Dobbe, and the MB l-like monoclonal antibodies, 
BT3.4 and Genox 3.53, were shown to isolate DS molecules, based on compari- 
sons to the DS molecules isolated by the DS-specific  heteroserum RbO3. RbO3 
has been shown (1) to isolate Ia molecules whose a and/3 chains have N-terminal 
amino acid sequence homology to murine I-A a  and B chains, respectively. The 
RbO3 +  BT3.4, RbO3 +  Genox 3.53, and RbO3 +  Baron mixing experiments 
demonstrate that the a  and ~ chains of Ia molecules isolated by BT3.4, Genox 1524  COMPLEXITY OF  HLA-DS MOLECULES 
3.53,  and  Baron  co-migrate  with  the  DS  ~  and  /3  chains,  respectively,  of Ia 
molecules isolated by RbO3. These data,  plus the previous demonstration  that 
the ~ chains of Ia molecules isolated by Genox 3.53 have N-terminal amino acid 
sequence  homology  to  murine  I-A  o~ chains  (5),  establish  that  BT3.4,  Genox 
3.53, Baron, and Dobbe are specific for DS molecules. 
Comparison of the/3 chain patterns of Ia molecules isolated by RbO3, BT3.4, 
Genox 3.53, Baron, and Dobbe indicates that the ELD cell line expresses at least 
two distinct DS/3 chains. Baron and Dobbe isolated Ia molecules containing only 
DSflz. BT3.4 isolated Ia molecules containing both DS/3 chains; however, in the 
BT3.4 gels, the spots of DSfl~ are more intense than  the spots of D8/32. Genox 
3.53 also isolated Ia molecules containing both DS/3 chains. However, in contrast 
to the BT3.4 gel, the spots of DSfl2 in the Genox 3.53 gels are more intense than 
the  spots  of DSfll.  Taken  together,  these  reciprocal  patterns  of/3  chain  spot 
intensities and the demonstration that D8/32 can be isolated without DS/31 indicate 
that this DRw6 homozygous cell line expresses at least two distinct DS/3 chains. 
In  addition  to  the  spots  of DS/3~ and  DS/32, the  RbO3,  BT3.4,  Genox  3.53, 
Baron, and  Dobbe gels contain additional  minor spots in their/3 chain regions; 
some of these minor  components are accentuated  in  the  RbO3  +  BT3.4  and 
RbO3 +  Genox 3.53 gels. These less intense spots may be minor components of 
DS/31 and/or DSfl2, or they may represent additional DS/3 chains that are present 
in smaller quantities than DS/31 and D8/32 or are less well labeled with methionine 
or leucine than  the major DS/3 chains.  The  finding that  a  DRw6 homozygous 
cell line expresses at least two distinct  DS/3 chains extends our previous obser- 
vation  that  a  DR5  homozygous  cell  line  expresses  two  DS  /3  chains  (6)  and 
suggests that the expression of at least two DS/3 chains by homozygous cell lines 
is a generalized phenomenon. 
The  studies presented  here also indicate that  the  ELD cell  line expresses at 
least two distinct DR ~ chains and a single DR ~ chain that combine to form two 
DR molecules.  Three  DR-specific monoclonal  antibodies  were  used to  isolate 
DR molecules in these studies; SG157, L227, and L243 have all been shown (1- 
3) to isolate Ia molecules that  have N-terminal  amino acid sequence homology 
to routine I-E molecules. SG157 and L243 isolated both DR molecules from the 
ELD  cell  line,  while  L227  isolated  only  the  DR/3~-containing  molecule.  The 
DR/32-containing Ia molecule was isolated alone when L243 was used to immu- 
noprecipitate an  L227-depleted  ELD antigen  preparation.  These results agree 
with  previous studies that  demonstrated  two distinct  DR molecules from  DR4 
(2), DR5 (6, 29), and DRw6 (3, 28) cells. 
Two of the four spots of DR/3~ co-migrated with the two spots of DS/3~ in the 
SG 157 +  RbO3 and SG 157 +  BT3.4 mixing gels. The coincident spots of DR/3~ 
and  DS/3~ were  formally  shown  to  belong  to  distinct  Ia  chains  in  sequential 
immunoprecipitation  experiments.  After complete removal  of both  DR mole- 
cules  by  immunoprecipitation  with  SG157,  BT3.4  still  isolated  Ia  molecules 
containing  DS/31 and  D8/32. Likewise, after  complete removal  of Ia  molecules 
containing  both  DS /3 chains  by immunoprecipitation  with  BT3.4,  SG157  still 
isolated  Ia  molecules containing  DR/31 and  DR/3~. Therefore,  the two spots of 
DR/3j and DS/31 that co-migrate represent glycosylated forms of distinct proteins 
which have similar physical characteristics when analyzed by this 2-D gel method. KARR ET  AL.  1525 
Comparison of the a  chains of Ia molecules isolated from the ELD cell line by 
the various anti-Ia  reagents suggests a degree of molecular complexity that has 
not been previously appreciated in studies at the protein level. The data shown 
in Figs.  1 and 4 indicate that the ELD cell line expresses at least three distinct Ia 
a  chains:  the DRa chain  isolated by SG157,  L227, and  L243;  the  DSal  chain 
isolated by both RbO3 and BT3.4; and the DSa2 chain isolated by RbO3, BT3.4, 
Baron, and Dobbe. DRa and DSa2 were each isolated in the absence of some or 
all of the other a  chains; this strongly indicates that each is a distinct Ia a  chain. 
DRa was isolated alone by SG157, L227, and L243. DSae was isolated alone by 
Baron and Dobbe. The DSal chain was not isolated alone by any of the reagents 
used in these studies; however, the existence of DSoq as a distinct a  chain can be 
reasonably deduced from  the  DS a  patterns  in  the  RbO3,  BT3.4,  Baron,  and 
Dobbe gels. The isolation of DSa2 without DSoq by Baron and Dobbe suggests 
that DSa~  is distinct from DSa2. The Genox 3.53 o~ pattern  is distinct from the 
RbO3, BT3.4, Baron, and Dobbe DS a patterns. The Genox 3.53 a pattern may 
represent an additional distinct DS a  chain; however, it is not possible, based on 
these  data,  to  exclude  the  possibility that  these  spots represent  precursors  of 
DSa~ or DS0t  2. The three Ia a chains identified in these studies have very similar, 
sometimes partially coincident,  isoelectric points and  molecular weights.  These 
marked physical similarities,  coupled with the technical difficulties of optimally 
resolving both the basic/3 chains and the acidic ~ chains in the same isoelectric 
focusing gel or nonequilibrium  pH gradient electrophoresis gel, have undoubt- 
edly contributed  to previous  difficulties in  resolving the  degree  of Ia  a  chain 
complexity shown here. 
The expression of at least two distinct DS a  chains and at least two distinct DS 
/3 chains by the ELD cell line raises the possibility that one or both of the DS/3 
chains  may associate  with  both  of the  two  DS a  chains  to  form  multiple  DS 
molecules. The present data indicate that a  minimum  of two DS molecules are 
expressed by this  DRw6 homozygous cell  line;  however,  there is the potential 
for the expression of four different DS molecules (DSaI:DS/31;  DSal:DS/3~;  DSa2: 
DSBI; and DSo~2:DS/32  ). Although it seems likely that all of these molecules exist, 
it is not possible, based on the present data, to identify all of these potential  DS 
molecules because RbO3, BT3.4, and Genox 3.53 all precipitate more than one 
DS molecule. The possibility that  a  single DS/3 chain  may associate with more 
than  one  DS  a  chain  to  form additional  distinct  DS  molecules has  important 
implications for our understanding  of the functions of DS molecules because of 
the amplification of Ia antigenic diversity which would result. 
The data presented here document for the first time that there is heterogeneity 
of the molecular specificities of anti-Ia  reagents  that  define the  MB1  or MB1- 
like antigens in population studies. Analysis of Ia molecules immunoprecipitated 
by two MB1  allosera  and  two MBl-like  monoclonal  antibodies  revealed three 
distinct  2-D gel patterns  of Ia  molecules.  The  2-D gel patterns  observed with 
two MB1 allosera,  Baron and  Dobbe, include DSa~ and D8/32, but not DScq or 
DS/31. The 2-D gel pattern of BT3.4 includes DSal, DSa2, DS/31, and DS/32. The 
2-D gel pattern of Genox 3.53 includes DS/3~ and DS/32, and a DS a  chain(s) that 
may be related to DSa~ or DSa2. Importantly, there were reciprocal quantitative 
differences in  the  intensities of the spots of DS/3t and  DS/32 in  the BT3.4  and 1526  COMPLEXITY  OF  HLA-DS  MOLECULES 
Genox 3.53 gels, suggesting that these reagents isolated different populations of 
Ia  molecules. Therefore, this  DRw6  homozygous cell line appears  to  express 
three distinct MBl-related determinants on DS molecules: the MB1  aliodeter- 
minant recognized by Baron and Dobbe, the MBl-like determinant recognized 
by BT3.4, and another MBl-like determinant recognized by Genox 3.53.  The 
present data do not allow assignment of these determinants to a chains,/3 chains, 
or combinatorial determinants.  These findings underscore the importance of 
designating in the nomenclature of the serologically defined Ia alloantigens the 
potential differences between the specificities of alloreagents and  monoclonal 
antibodies  that  have  the  same  reactivity patterns  in  population  studies.  The 
designation of such monoclonal antibodies as  MBl-like or  MB3-1ike  (20),  for 
example, would seem to accomplish this goal without unduly complicating the 
nomenclature. These considerations will undoubtedly assume greater importance 
as more monoclonal antibodies with specificities similar to recognized Ia allo- 
specificities become available for clinical tissue typing. 
The MB1 aliodeterminant is located on only one of the multiple DS molecules 
expressed by the DRw6 homozygous cell line used in these studies. This finding 
is  in  general agreement with  our recent observation  (6)  that  the  MB3/MT4 
allodeterminant is present on only one of the two DS molecules that we identified 
from a  DR5 homozygous cell line. In studies with the DR5 cell line, we found 
no alloantisera which isolated the non-MB3/MT4-bearing DS molecule (6, 29). 
Together with the studies presented here, this suggests that the restriction of 
the MB1 and MB3/MT4 allodeterminants to only one of multiple DS molecules 
may be an example of the generalized organization of the DS-related, serologi- 
cally defined alloantigens. Moreover, these data raise the possibility that the DS 
molecules that bear the MB1  and MB3/MT4 allodeterminants, and perhaps the 
other  DS-related  ailodeterminants,  are  more  alloimmunogenic  than  the  DS 
molecules which do not bear these allodeterminants. 
The Ia molecules expressed by another DRw6 homozygous cell line, WT46, 
have been investigated by Shackelford et al. (28) using 2-D gel electrophoresis. 
These studies demonstrated that the WT46 cell line expresses two DR molecules 
which could be separated using L243 and L227.  Interestingly, the DR/3 chain 
patterns from WT46 are very similar to the DR fl chain patterns of ELD. They 
also used several anti-MB1 allosera and the anti-MBl-like monoclonal antibody, 
Genox 3.53,  to isolate DS molecules from WT46.  The anti-MB1  allosera and 
Genox 3.53 all isolated a single Ia molecule composed of a/~ chain analogous in 
position to DS/32 in the present studies and an a  chain distinct from the DR 
chain. The two spots of this single DS fl chain, like DS/~2 in the present study, 
were very closely related to the major spots of the basic DR/3 chain. However, 
in the studies of Shackelford et al., Genox 3.53 did not appear to isolate a second 
DS ¢3 chain corresponding to DSfl~. It seems most likely that a second DS/3 chain 
was not detected in their studies because of the finding shown in Fig. 3: DSfll is 
sometimes not visible or is only faintly visible in Genox 3.53 precipitates, while 
the  spots  of  DS/32 are  moderately  intense.  Indeed,  our  initial  Genox  3.53 
immunoprecipitate from an ELD antigen preparation revealed only DS/32 (data 
not shown). Although it seems unlikely, it is also possible that the WT46 cell line 
does not express a second DS/3 chain analogous to DSfl~. KARR  ET  AL.  1527 
Because of the relatively recent identification of DS molecules and the paucity 
of  DS-specific  reagents,  the  functional  role  of  DS  molecules  has  not  been 
extensively investigated. The studies reported to date indicate that DS molecules, 
like the more extensively studied DR molecules, are important  in the function 
of the human  immune system.  In studies using the  DS-specific reagent  RbO3, 
Gonwa  et  al.  (30)  demonstrated  that  there  are  two  populations  of adherent 
peripheral blood monocytes: DS+,DR  + and DS-,DR  ÷. Importantly, only the DS  ÷ 
monocytes could  present  antigen  to  T  cells.  Corte  et  al.  (31)  found  that,  in 
contrast  to  an  anti-DR  monoclonal  antibody,  the  anti-MBt-tike  monoclonal 
antibody, BT3.4, blocked the generation of cytotoxic T  lymphocytes but did not 
inhibit T  cell proliferation in the mixed lymphocyte culture. However, Koide et 
al.  (32)  reported  that  another  anti-MBl-like  monoclonal  inhibited  the  mixed 
lymphocyte  culture.  The  evidence  presented  here  for  the  heterogeneity  of 
molecular specificities of anti-MB1  and anti-MB l-like reagents may provide an 
explanation  for  these  apparently  disparate  results  regarding  the  role  of  DS 
molecules bearing MBl-like determinants in the mixed lymphocyte culture. The 
finding  that  homozygous  cells  express  multiple  DS  molecules  has  important 
implications for future studies of the functional role of DS molecules. 
Recent studies at the gene level have greatly accelerated the understanding of 
the  portions  of the  HLA complex  that  encode  Ia  molecules.  Genomic  clones 
and/or cDNA clones for multiple Ia a and/3 chain genes have now been isolated. 
Present evidence indicates that there are at least three DS a  chain genes (33), a 
single DR ~ chain gene (34-38), and a single SB a  chain gene (39, 40). These/3 
chain genes have been identified:  three  DR, two DS (39, 40), and one SB (39, 
41). The recent identification  of at least three DS a  chain genes by Auffray et 
al.  (33) is particularly pertinent  to the data presented in this paper.  They have 
used a  cDNA  probe  for  the  DS  o~ chain  gene  to  investigate  several  deletion 
mutant  cell  lines  that  ai'e  DR-null,  MBl-positive  or  DR-null,  MBl-negative. 
When the cell lines were analyzed with the DS a probe under sensitive conditions, 
at least three different DS a  chain genes were identified in the DR-null,  MB1- 
positive mutants.  Interestingly, in the context of our data, only one of these DS 
chain  genes was absent from the MBl-negative mutants.  Therefore,  the loss 
of only one  of the  three  DS  ot chain  genes  was correlated  with,  but  was not 
necessarily the sole basis for, the loss of the serologically defined MB1 phenotype. 
However, these studies did not include analysis of the DS/3 chain genes in the 
MBl-negative mutants.  Therefore, the correlation of the loss of only one DS o~ 
chain gene with the loss of the MB1 phenotype is compatible with three, as yet 
unresolved, possibilities: (a) the MB1 allodeterminant  is located on the a  chain 
that  is  encoded by the  lost  DS  a  chain  gene,  (b)  the  MB1  allodeterminant  is 
located on a  DS/3 chain whose gene was lost along with the DS a  chain gene in 
the mutant, or (c) the MB1 allodeterminant is a combinational determinant whose 
Presence is dependent on the expression of both the lost DS ot chain gene and 
an  as yet unidentified  13 chain  gene.  The  data presented  in this paper  for the 
expression of at least two distinct DS a  chains and the localization  of the MB1 
allodeterminant  to a  single  DS molecule based on  studies at the  protein  level 
agree with  the studies  of Auffray et al.  (33) at  the gene  level.  Moreover,  the 
present  studies  suggest  a  basis at  the  level of expressed  Ia  molecules for  the 1528  COMPLEXITY  OF  HLA-DS  MOLECULES 
finding that the loss of only one of three DS a  chain genes is associated with the 
loss of the  MB1  phenotype.  As discussed previously, the MB1 allodeterminant 
can be localized to the DSa2:DS3u molecule from the ELD cell line.  Molecules 
containing DSal or DS3, do not bear the MB1 ailodeterminant  (although these 
molecules do bear MB l-like determinants defined by the monoclonal antibodies). 
Therefore, in a hypothetical deletion mutant, the loss of genes that encode DSau 
and/or  DS32  would  be  expected  to  be  associated  with  the  loss  of the  MB1 
phenotype  in  serologic  testing.  Moreover,  these  data  predict  that  a  DR-null, 
MBl-negative mutant which has lost the genes encoding DSa2 and/or DS32, but 
still  contains the DSal  chain gene and the DS3, chain gene, would still  express 
Ia molecules recognized by BT3.4 and perhaps Genox 3.53. The data presented 
here  underscore  the  utility  of continued  studies  of Ia  molecules at  both  the 
protein and gene levels. 
Summary 
Ia molecules expressed by an  HLA-DRw6 homozygous cell line were immu- 
noprecipitated with anti-Ia allosera and monoclonal antibodies and analyzed by 
2-D gel electrophoresis.  The DRw6 homozygous cell line was shown to express 
two  DS  3  chains;  this  observation  extends  our  previous  finding  that  a  DR5 
homozygous cell line expresses two DS 13 chains and suggests that the expression 
of at  least  two  DS  3  chains  by  DR  homozygous  cell  lines  is  a  generalized 
phenomenon.  The data presented  here document for the first time that a  DR 
homozygous cell line expresses at least two DS a  chains. Therefore, this cell line 
expresses at least two DS molecules with the potential for the expression of four 
DS molecules.  In  agreement  with  previous reports,  the cell line  was shown to 
express two DR 3  chains  and one  DR ot chain  that  combine  to form  two DR 
molecules.  The  molecular specificities of two MB1  allosera and  two MBl-like 
monoclonai antibodies were also compared in these studies.  Both MB1 allosera 
isolated a single DS molecule, while the MB l-like monoclonal antibodies isolated 
at least two DS molecules. Therefore,  these studies document for the first time 
that anti-Ia  reagents which are specific for the MB1  or MBl-like determinants 
in population studies do not recognize the same la molecules in immunochemical 
studies. The data presented here for the expression of at least two DS a  chains 
and  the  location  of the  MB1  allodeterminant  on  only  one  of  multiple  DS 
molecules are in agreement with recent studies at the gene level. 
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